Admission
The Call for Admission to the PhD Degree in Pharmaceutical Sciences is issued every year between April and June.
Undergraduates can also apply as long as they achieve the qualification by the date of enrollment in the course.
Possible reference for further information: Dr. Rosa De Vivo tel. 081-678745
Admission procedure
Evaluation of qualifications: admission of candidates is based on the evaluation of their Curriculum studiorum and on the qualifications presented at the time of application. In compiling their CVs, candidates must include the following information:
- date of graduation and grade of the master's degree
- detailed list of exams taken and relative marks
- any scholarships or research grants obtained (and similar qualifications)
- certificates of participation in post-graduate university courses
- certificates of participation in previous research groups
- certificates of participation in internships
- prizes or other qualifications that can be evaluated (eg second degrees, etc.)
The request for admission may possibly be supplemented by a summary of the degree thesis, the list of any scientific publications and a possible reference letter from a university professor.
Linguistic knowledge: Candidates must also demonstrate good knowledge of a foreign language. Knowledge of the foreign language will be assessed by reading and translating a text (identified during the test itself) into the foreign language chosen by the candidate among those determined by the announcement, and a brief conversation on the content of what has been read.
Oral exam: the oral exam is aimed at ensuring a suitable comparative evaluation of the candidates and at ascertaining the preparation and aptitude of the candidate for scientific research. The qualifications and topics covered by the oral exam must be relevant to the relevant scientific-disciplinary sectors of the PhD course; the interview will focus on a specific topic chosen by the candidate from the list that will be available in this page after the opening of the call.
Download: admission results 40 cycle
Download: Results of oral examination 40 cycle
Doctoral Course in Pharmaceutical Sciences –XXXIX Cycle-List of topics for the oral admission
|
Topic |
Title |
Tutor e co-tutor, special fundings |
|
Bioactive non-viral nanovectors for RNA delivery |
Prof. De Rosa Giuseppe CN3-Spoke 3 (Neurodegeneration) |
|
|
Design and synthesis of antisense oligonucleotides (ASOs) modified with small molecules |
Prof.ssa Sepe Valentina CN3-Spoke 4 (Metabolic and Cardiovascular disease) |
|
|
Design of Modulators of miRNAs Involved in Cardiovascular and Metabolic Disorders through Machine/Deep Learning Techniques and Biosimulations |
Prof. Lavecchia Antonio CN3-Spoke 4 (Metabolic and Cardiovascular disease) |
|
|
Inhalable RNA-loaded nanoplatforms for local management of lung fibrosis and chronic inflammation |
Proff. Ungaro Francesca-Costabile Gabriella CN3-Spoke 5 (Inflammatory and Infection disease) |
|
|
Pharmacokinetic and pharmacodynamic evaluations of RNA-loaded nano-delivery systems for the treatment of pulmonary inflammation |
Prof.ssa D'Emmanuele di Villa Bianca Roberta
CN3-Spoke 5 (Inflammatory and Infection disease) |
|
|
Design, synthesis, structural characterization, and evaluation of the biological properties of therapeutic oligonucleotides based on DNA, RNA and analogs |
Prof. Galeone Aldo
CN3-Spoke 6 (RNA Drug development) |
|
|
Physicochemical investigations on RNA drug based and energetics of their interaction with biomolecular targets |
Prof.ssa Giancola Concetta
CN3-Spoke 6 (RNA Drug development) |
|
|
Application of computational methods to investigate and optimize the structural stability and the pharmacokinetic properties of lipid-based RNA nanocarriers |
Prof.ssa Moraca Federica
CN3-Spoke 7 (Biocomputing) |
|
|
Development of chicken ChorioAllantoicMembrane (CAM)-based cancer models to screen trafficking, delivery efficiency, and toxicity of RNA based nanoplatforms |
Prof.ssa Russo Annapina
CN3-Spoke 8 (Platform for DNA-RNA delivery) |
|
|
Peptide-based nanostructures as delivery tools for active pharmaceutical ingredients |
Proff. Diaferia Carlo-Accardo Antonella
CN3-Spoke 8 (Platform for DNA-RNA delivery) |
|
|
Polymeric nanoplatforms for precision targeting of siRNA to solid tumors |
Prof.ssa Conte Claudia CN3-Spoke 8 (Platform for DNA-RNA delivery) |
|
|
Development of a Proteomic Platform to Characterize Nanoparticles Corona Proteins |
Prof.ssa Zampella Angela
CN3-Spoke 8 (Platform for DNA-RNA delivery) |
|
|
Validating acid nucleic-based drugs using in vitro and in vivo models of cancer |
Prof. Cirino Giuseppe CN3-Spoke 9 (From target to therapy and competence center) |
|
|
Maternal separation and cerebellum: a study of psychological and neuronal vulnerability to early life stress |
Proff. Miniaci Maria Concetta-Perrone Capano Carla
PE (MNESYS) |
|
|
Neuronal control of intestinal barrier function |
Prof.ssa Aviello Gabriella
PE (MNESYS) |
|
|
Design and synthesis of molecular hybrids between drugs for dermatological disorders or wound healing and H2S donors |
Prof. Frecentese Francesco
DM217(DAMOR) |
|
|
Discovery of potent and selective Direct Antiviral Agents (DAA) |
Proff. Summa Vincenzo-Guidotti Luca
DM217 (Ospedale San Raffaele) |
|
|
Analysis, composition, exposure and risk assessment of atmospheric particulate matter and characteristic pollutants supporting public organizations |
Proff. Perissutti Elisa-Magli Elisa
DM118 Pubblica Amministrazione |
|
|
Molecular and cellular mechanisms linking air pollution and lung diseases |
Prof.ssa Roviezzo Fiorita
DM118 Pubblica Amministrazione |
|
|
Computational approaches of Drug utilization applied to Health Big Data to support health policies for chronicity management |
Proff. Menditto Enrica-Orlando Valentina
DM118 Pubblica Amministrazione |
|
|
Computational methods of Drug Utilization and Pharmacoeconomics for Healthcare policies in order to develop new regulatory processes for Advanced Therapies |
Proff. Orlando Valentina-Menditto Enrica.
DM118 Pubblica Amministrazione |
|
|
Mimetics of SOCS proteins as antinflammatory therapeutics in cancer |
Proff. Marasco Daniela-Falcigno Lucia Convenzione AIRC |
|
|
Portable diagnostics for liquid biopsy application |
Prof. Cinti Stefano Convenzione AIRC |
|
|
Elucidating the role of Neuregulin 1 on the neuroinflammatory and behavioral profile in the early-life immune activation mouse model of autism: focus on the brain-gut axis |
Proff. Mattace Raso Giuseppina-De Simone Roberta
Convenzione ISS |
|
|
Targeting arginase 2 to disrupt the immunosuppressive tumour microenvironment and promote gastric cancer response |
Dott.ssa Sodano Federica
Convenzione AIRC |
|
|
Preclinical development of Ru-based nanoformulation for cancer therapy |
Proff. Irace Carlo-Santamaria Rita |
|
|
New RNA-based therapeutic strategies to overcome chemoresistance in colorectal cancer |
Proff. Russo Giulia-Russo Annapina |
|
|
The role of phosphodiesterases in regulating the function of innate and adaptive immune cells in chronic respiratory diseases |
Proff. Ianaro Angela-Tenore Giancarlo |
|
|
TRPV3 in intestinal inflammation and colitis-associated cancer: functional role and pharmacological targeting |
Proff. Pagano Ester-Izzo Angelo |
|
|
Proposed Research Theme: IL-17A/IL-17RA axis in the association of autoimmune diseases with cardiovascular complications |
Proff. Maione Francesco-Cirino Giuseppe |
|
|
Metabolites from Cannabis – green expansion of chemical and biological space |
Proff. Chianese Giuseppina-Taglialatela Orazio |
|
|
α-synuclein/hDAT interaction: a new target against Parkinson's Disease |
Proff. De Simone Alfonso-Stornaiuolo Mariano |
|
|
Design and synthesis of nature-inspired compounds as potential anti-inflammatory/anticancer agents |
Proff. De Marino Simona-D'Auria Valeria |
|
|
Fragment-Based Ligand and Drug Discovery (FBLDD) via marine natural products to fight insulin resistance and inflammatory disorders associated with metabolic syndrome |
Proff. Imperatore Concetta-Menna Marialuisa |
|
|
Design, synthesis, physicochemical characterization, and biological evaluations of new drugs for inflammatory-based disease treatmen |
Proff. Rimoli Maria Grazia- Albrizio Stefania |
|
|
Antimicrobial peptides as promising agents able to counteract the antibiotic resistance of bacteria and protozoa |
Proff. Grieco Paolo-Isabel Gomez Monterrey |
|
|
Holistically sustainable multi-modal β-amyloid imaging |
Proff. Brindisi Margherita-Summa Vincenza |
|
|
Development of Ligands targeting Adenosine receptor A2A |
Proff. Brancaccio Diego-Carotenuto Alfonso |
|
|
Development of supramolecular peptide nanosystems for the delivery of new bioinorganic drugs |
Proff. Tesauro Diego-Morelli Giancarlo |
|
|
Multimeric G-quadruplex–forming DNA sequences: from characterization to the development of specific binders |
Proff. Pagano Bruno-Giustiniano Mariateresa |
|
|
Emerging toxins in italian seas and risks for human health |
Proff. Dell'Aversano Carmela- Varra Michela |